The category [] Weight management drugs and high-cost specialty treatments are expected to have the biggest impact on private drug plans this year, according to Telus Healths annual drug pipeline report
Future Applications of Automated Diagnosis Verification and Conclusions The successful implementation of automated diagnosis verification for GLP-1 RA demonstrates the potential for streamlined utilization management approaches in pharmacy benefit design
"This bridge program will now allow Medicare beneficiaries access to GLP-1 medications for weight loss through a monthly subscription model, which raises important questions about who pays, how much it will cost, and whether the program can be sustained long term," Kevin Thompson, the CEO of 9i Capital Group and the host of the 9innings podcast, told Newsweek
Scientific Classification A stabilized 44-amino-acid class B1 peptide-receptor ligand
Contact your VA provider to find out more about your options
Edo Aarts, bariatrisch chirurg, specialist in het begeleiden van mensen met overgewicht en medeoprichter van Overgewicht Nederland en WeightWorks